Effects of the HDAC6/8 Inhibitor MC1568, Alone and in Combination With Fluconazole, in Non‐ Albicans Candida Species Infections
MicrobiologyOpen · 2026
DOI: 10.1002/mbo3.70188 ↗Kurz gefasst
Fachartikel in der Zeitschrift MicrobiologyOpen, 2026. Verfasst von Andrea Giammarino und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy. Hauptthemen laut MEDLINE: Fluconazole, Antifungal Agents, Histone Deacetylase Inhibitors, Candida. Die Arbeit nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: This study was supported by Ricerca Ateneo Sapienza Project protocs. RP12218147BEEF07 (2022, to L.A.), RM123188F708EDE9 (2023, to S.V.), AR12419078302CFC (2024….
Abstract (Originalsprache)
Fungal infections pose a severe health risk, particularly in immunocompromised individuals, with Candida species being a leading cause of bloodstream infections. The rise of non‐ albicans Candida (NAC) infections, accounting for 35%–65% of candidemia cases, underscores the urgent need for novel antifungal strategies. Current treatments, including echinocandins and azoles, are increasingly challenged by drug‐resistant strains. This study evaluated the antifungal efficacy of three clinically approved histone deacetylase inhibitors (HDACi)—Vorinostat, Romidepsin, and Tucidinostat—along with the HDAC6/8‐selective inhibitor MC1568, alone and in combination with Fluconazole. The Fluconazole/MC1568 combination exhibited significant synergistic effects, reducing biofilm formation and enhancing antifungal activity, particularly against C. guillermondii , C. lusitaniae , and C. tropicalis . In Galleria mellonella larvae, this combination increased survival by 70% in C. tropicalis infections. When tested in human retinal pigment epithelium (RPE) cells, three different MC1568/Fluconazole combinations displayed low toxicity. These findings highlight the potential of the HDAC6/8 inhibitor MC1568 as adjunct therapy to combat NAC infections, warranting further research to optimize antifungal efficacy while minimizing toxicity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy.
- Department of Drug Chemistry and Technologies, Sapienza University of Rome, Rome, Italy.
- IBPM Institute of Molecular Biology and Pathology, CNR National Research Council of Italy, Rome, Italy.
- Departamento de Micología, Instituto de Medicina Regional, Universidad Nacional del Nordeste, Argentina.
ORCID-Profile: Letizia Angiolella
Förderung
- This study was supported by Ricerca Ateneo Sapienza Project protocs. RP12218147BEEF07 (2022, to L.A.), RM123188F708EDE9 (2023, to S.V.), AR12419078302CFC (2024…
Zitieren
APA
Giammarino, A., Lambona, C., Raucci, A., Simonetti, G., Macrì, S., Iuzzolino, A., Trisciuoglio, D., Valente, S., Giusiano, G., Angiolella, L., & Mai, A. (2026). Effects of the HDAC6/8 Inhibitor MC1568, Alone and in Combination With Fluconazole, in Non‐ Albicans Candida Species Infections. MicrobiologyOpen. https://doi.org/10.1002/mbo3.70188
Vancouver
Giammarino A, Lambona C, Raucci A, Simonetti G, Macrì S, Iuzzolino A, et al. Effects of the HDAC6/8 Inhibitor MC1568, Alone and in Combination With Fluconazole, in Non‐ Albicans Candida Species Infections. MicrobiologyOpen. 2026. doi:10.1002/mbo3.70188
BibTeX
@article{Giammarino2026,
author = {Giammarino, Andrea and Lambona, Chiara and Raucci, Alessia and Simonetti, Giovanna and Macrì, Salvatore and Iuzzolino, Angela and Trisciuoglio, Daniela and Valente, Sergio and Giusiano, Gustavo and Angiolella, Letizia and Mai, Antonello},
title = {Effects of the HDAC6/8 Inhibitor MC1568, Alone and in Combination With Fluconazole, in Non‐ Albicans Candida Species Infections},
journal = {MicrobiologyOpen},
year = {2026},
doi = {10.1002/mbo3.70188}
}
EUVIMED